Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat Insomnia (EU)(?)

Council Members in this Study Group: 32

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Yves Dauvilliers, MD
Head of Sleep Medicine
Montpellier University Hospital Center

Yves Dauvilliers, MD, is Division Head of Sleep Medicine at the University Hospital of Montpellier, France. Dr. Dauvilliers has expertise in the treatment of all sleep disorders. His basic research interests, using electrophysiological and genetic techniques, are narcolepsy, parasomnia and sleep with...

Related Study Groups

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Good but not that much better | 01-14-2008
Analysis of: New Inhalation Device With Aclidinium Bromide May Offer Advantages To COPD Patients | www.medicalnewstoday.com
Author: GLG Expert Contributor

This is a good inhaler but there is no current evidence the drug is signifcantly better than spiriva.

Encouraging news for a novel theraputic approach | 06-22-2007
Analysis of: Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan | www.pipelinereview.com
Author: GLG Expert Contributor

This is exciting news about the improvement in patient outcomes. it is unfortunate that they decdied to end the trial early however as with  just 41 patients in the trial - any adverse events that the treatment might cause may arise during wider usage.

beware Biowa- anti-Il-5 doesnt work in humans! | 11-03-2006
Analysis of: BioWa, Inc. Begins Phase 1 Clinical Trial in Asthma | www.pipelinereview.com
Author: GLG Expert Contributor

Recent renewed interest in a failed anti-cytokine approach for asthma.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*
  • Office Based Private Practice or Clinic
  • Government/Military Hospital or Clinic
  • Facility, Academic Medical Center
  • Lab, Academic Medical Center
  • Medical Equipment & Supplies Manufacturer

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Division Head
  • Physician - Director
  • Professor
  • Medical Director
  • National Sales Manager
  • Lab Director
  • Owner
  • Physician - Department Chair
  • Lecturer

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387